DRKS00020522已完成不适用
Evaluation of the Immunoglobulin-G-Dried Blot Spot (IgG-DBS) diagnostic tool kit compared to the standard method for monitoring serum IgG levels - IgG-DBS_2019
niversitätsklinikum Freiburg, Institut für Immundefizienz & Centrum für Chronische Immundefizienz0 个研究点目标入组 150 人开始时间: 2020年1月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patient is diagnosed having PID
- •- Patient planned to get an IV blood drawing for serum Ig level determination at a regular hospital visit
- •- Patient receives Ig substitution treatment (IV or SC)
- •- Patient is able to perform a finger prick and the DBS spotting either independently after instruction or with support of medical staff
排除标准
- •- Participation in any interventional clinical study within the last 30 days
- •- Patient does not receive Ig substitution treatment (IV or SC)
研究者
相似试验
已完成
不适用
A pilot study the effectiveness of immune globulin for ALI / ARDSJPRN-UMIN000005422Division of Respirology, department of internal medicine, Jikei University Hospital10
尚未招募
不适用
comparison of immunoglobulin Y and probiotics in reduction of bacterial loadCTRI/2020/06/026249DR SAKSHI JAI
进行中（未招募）
1 期
Efficacy of immunoglobulins in pediatric early-onset corticosteroid nephrotic syndromeChildhood-Onset steroid-dependent nephrotic syndromeMedDRA version: 20.1Level: PTClassification code 10029164Term: Nephrotic syndromeSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2017-000826-36-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)90
已完成
不适用
Barrett?s oesophagus screening trial in a case control studyBarrett's oesophagusDigestive SystemBarrett's oesophagus/oesophageal adenocarcinomaISRCTN12730505Cambridge University Hospitals NHS Foundation Trust (UK)1,400
已完成
3 期
Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki diseaseKawasaki diseaseJPRN-UMIN000000940Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group392